Dedicated to improving the lives of ALS patients and their families in Monmouth and Ocean Counties
  Home   ALS Facts   About Us   How to Help   News & Events   Photo Gallery   Resources   Contact Us  
  ALS STATS
ALS can happen to anyone
   
ALS has no known cause
   
ALS is diagnosed in 14 people everyday
   
ALS affects 30,000 people in the US at any given time
   
ALS is always fatal
   
   
   
   
ALS FACTS: A HARD-HITTING DISEASE

What is ALS?
ALS, Amyotrophic Lateral Sclerosis, commonly called Lou Gehrig’s disease, affects nerve cells in both the spinal cord and brain. This causes motor neurons to degenerate and eventually die, leading to muscle paralysis.

What causes ALS?
There is currently no known cause for the disease.

Is ALS a rare disease?
It is more common than you might expect. About 5,600 people in the US are diagnosed with ALS each year and it is estimated that as many as 30 ,000 Americans have the disease at any given time. In fact, ALS is as common as multiple sclerosis.

Who gets ALS?
ALS can happen to anyone. It most commonly occurs in men and women between the ages of 35 and 70, but people of  any age, race, ethnicity, location or income group can get ALS.

What are the symptoms of ALS?
Early signs of ALS can include muscle weakness, stiffness and cramps, tripping, dropping things, abnormal fatigue of the arms and/or legs, twitches, slurred speech and uncontrollable periods of laughing or crying. Later signs include paralysis of the arms, legs, and trunk muscles, as well as the muscles that control vital functions such as speech, swallowing, and breathing.

Does ALS affect a person’s mind?
No. The vast majority of ALS patients remain sharp despite the progressive deterioration of their bodies.

How long do people with ALS survive?
The average life expectancy is two to five years.

Can ALS be cured?
No, there is no known cure at this time. However, because of advances in research and medical care, many ALS patients are living longer, more productive lives.

What progress had been made to treat ALS?
Rilutek®, the first treatment to alter the course of ALS, was approved by the FDA in late 1995.
This antiglutamate drug was shown scientifically to prolong the life of persons with ALS by at least a few months. More recent studies suggest Rilutek® slows the progress of ALS, allowing the patient more time in the higher functioning states when their function is less affected by ALS.

To learn more about ALS, visit Resources.
Riverview Medical Center • 1 Riverview Plaza • P. O. Box 8157 • Red Bank, NJ 07701 • 732.450.2677
Site Map Privacy Policy ©2009 Joan Dancy & PALS Foundation
Site Design: Andiamo Creative Company  
Site Programming: ForeFront Inc.